NeuroKaire
Precision medicine for depression
What they do
Personalized medical testing platform for depression treatment. Using biomarkers to match patients with the right medication from the start.
Since then
- 2017
- Founded.
- 2021
- Series A, $10M.
- 2025
- Launched the first blood test to personalize depression treatment.